The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized double-blind placebo-controlled trial of celecoxib for radiation-induced oral mucositis.
Rajesh V. Lalla
Consultant or Advisory Role - BioAlliance Pharma; Cangene; Evolife Laboratories; INGAL; Merck; Sucampo Pharmaceuticals
Research Funding - Evolife Laboratories; Pfizer
Linda E. Choquette
No relevant relationships to disclose
Kathleen F. Curley
No relevant relationships to disclose
Robert J. Dowsett
No relevant relationships to disclose
Richard S. Feinn
No relevant relationships to disclose
Upendra P. Hegde
No relevant relationships to disclose
Carol C. Pilbeam
No relevant relationships to disclose
Andrew L. Salner
No relevant relationships to disclose
Stephen T. Sonis
Employment or Leadership Position - Biomodels
Consultant or Advisory Role - ActoGeniX; Alder Biopharmaceuticals; Avaxia Biologics; Clinical Assistance Programs; Pfizer; Piramal; Polymedix; SciClone; Synedgen
Douglas E. Peterson
Consultant or Advisory Role - ActoGeniX; Alder Biopharmaceuticals; Astellas Pharma; CuraGen; Endo Pharmaceuticals; Merck; Otsuka; Pfizer